The Panbio Dengue IgG Indirect ELISA is for the qualitative detection of IgG antibodies to dengue virus serotypes (1, 2, 3 and 4) in serum as an aid in the clinical laboratory diagnosis of patients with clinical symptoms and past exposure consistent with dengue fever.

The Panbio Dengue IgG Capture ELISA is for the qualitative detection of IgG antibodies to dengue virus (serotypes 1, 2, 3 and 4) in serum. This test is intended as an aid in the clinical laboratory diagnosis of secondary dengue virus infection, and can be used in conjunction with the Panbio Dengue IgM Capture ELISA for the presumptive differentiation between primary and secondary infection. The Panbio Dengue IgG Capture ELISA offers an alternative to the HAI assay for the serological diagnosis of secondary dengue infections as it reduces inter-laboratory variation in dengue serology through the use of a standard cut-off serum.

The Panbio Dengue IgM Capture ELISA is for the qualitative detection of IgM antibodies to dengue antigen in serum, as an aid in the clinical laboratory diagnosis of patients with clinical symptoms consistent with dengue fever. Detection of IgM antibodies to dengue virus by ELISA is a valuable procedure, particularly in second and subsequent infections where the occurrence of complications is high. Serum IgM antibodies can be detected from dengue patients as early as three to five days after the onset of fever and generally persist for 30 - 90 days, although detectable levels may be present eight months post-infection.